Relay Therapeutics, Inc. (RLAY) Insider Trading
Over the last 3 months, RLAY insiders made 0 open-market buys and 12 sales, a net sale of -$6.6M (SEC Form 4). Over the last 6 months, 211 institutions increased and 119 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
12
Net (3m)
-$6.6M
Insider trades by month Buys Sells
Mar
Apr
May
Jun
Jul
Aug
Context3-month price +45.6%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Patel Sanjivdirector, officer: President and CEO | Sell | 48,199 | $20.33 |
| Aug 18, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 17,717 | $19.74 |
| Jul 30, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 1,459 | $18.61 |
| Jul 30, 2026 | Rahmer Peterofficer: See remarks | Sell | 748 | $18.61 |
| Jul 30, 2026 | Bergstrom Donald Aofficer: President, R&D | Sell | 2,237 | $18.61 |
| Jul 8, 2026 | Patel Sanjivdirector, officer: President and CEO | Grant | 3,056 | $6.95 |
| Jul 8, 2026 | Bergstrom Donald Aofficer: President, R&D | Sell | 8,660 | $18.71 |
| Jul 8, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 17,717 | $18.69 |
| Jul 8, 2026 | Patel Sanjivdirector, officer: President and CEO | Sell | 48,199 | $19.58 |
| Jul 2, 2026 | Rahmer Peterofficer: See remarks | Sell | 50,000 | $19.09 |
| Jul 2, 2026 | Rahmer Peterofficer: See remarks | Grant | 3,056 | $6.95 |
| Jun 24, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Option | 51,560 | $4.45 |
| Jun 24, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Option | 61,563 | $5.22 |
| Jun 24, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 51,560 | $16.97 |
| Jun 24, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Option | 56,323 | $5.04 |
| Jun 24, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 17,717 | $17.01 |
| Jun 24, 2026 | Bergstrom Donald Aofficer: President, R&D | Option | 93,456 | $4.12 |
| Jun 24, 2026 | Bergstrom Donald Aofficer: President, R&D | Sell | 93,456 | $16.94 |
| Jun 10, 2026 | Murcko Markdirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | Mazumdar Clairedirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | HILL LINDA Adirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | Dable Habib Jdirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | Borisy Alexisdirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | INGRAM DOUGLAS Sdirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | COATS LONNELdirector | Grant | 32,947 | $14.09 |
| May 14, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 17,717 | $12.86 |
| Apr 30, 2026 | Bergstrom Donald Aofficer: President, R&D | Sell | 1,490 | $14.79 |
| Apr 30, 2026 | Rahmer Peterofficer: See remarks | Sell | 753 | $14.79 |
| Apr 30, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 972 | $14.79 |
| Apr 9, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 17,717 | $13.01 |
Source: RLAY SEC Form 4 filings, latest Aug 18, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their RLAY positions over the last 6 months (SEC Form 13F).
Increased
211
New positions
104
Reduced
119
Sold out
31
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | Unchanged | 27.9M | May 18, 2026 |
| SB INVESTMENT ADVISERS (UK) LTD | Unchanged | 27.9M | Aug 14, 2026 |
| FMR LLC | Increased | 20.1M | Aug 13, 2026 |
| COMMODORE CAPITAL LP | Unchanged | 17.0M | May 15, 2026 |
| Casdin Capital, LLC | Increased | 16.0M | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 15.3M | Aug 7, 2026 |
| CASDIN CAPITAL, LLC | Increased | 14.4M | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 14.1M | Aug 14, 2026 |
| BLACKROCK, INC. | Reduced | 13.0M | May 13, 2026 |
| Commodore Capital LP | Reduced | 12.0M | Aug 14, 2026 |
| STATE STREET CORP | Increased | 10.1M | Aug 7, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 9.8M | May 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 9.0M | Aug 13, 2026 |
| BELLEVUE GROUP AG | Reduced | 7.8M | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 7.7M | Aug 14, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.